Kirtane, A. J., Stoler, R., Feldman, R., Neumann, F.-J., Boutis, L., Tahirkheli, N., … Kereiakes, D. J. (2021). Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent. Circ Cardiovasc Interv, 14(3), e010144. https://doi.org/10.1161/CIRCINTERVENTIONS.120.010144

Kirtane, Ajay J., Robert Stoler, Robert Feldman, Franz-Josef Neumann, Loukas Boutis, Naeem Tahirkheli, Ralph Toelg, et al. “Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.” Circ Cardiovasc Interv 14, no. 3 (March 2021): e010144. https://doi.org/10.1161/CIRCINTERVENTIONS.120.010144.

Kirtane AJ, Stoler R, Feldman R, Neumann F-J, Boutis L, Tahirkheli N, et al. Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent. Circ Cardiovasc Interv. 2021 Mar;14(3):e010144.

Kirtane, Ajay J., et al. “Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.” Circ Cardiovasc Interv, vol. 14, no. 3, Mar. 2021, p. e010144. Pubmed, doi:10.1161/CIRCINTERVENTIONS.120.010144.

Kirtane AJ, Stoler R, Feldman R, Neumann F-J, Boutis L, Tahirkheli N, Toelg R, Othman I, Stein B, Choi JW, Windecker S, Yeh RW, Dauerman HL, Price MJ, Underwood P, Allocco D, Meredith I, Kereiakes DJ. Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent. Circ Cardiovasc Interv. 2021 Mar;14(3):e010144.